Markets › India › NSE › AJANTPHARM

Ajanta Pharma Ltd

NSE:AJANTPHARMHealthcareNSE:CNX500NSE:CNXPHARMA

₹3,298.90−0.90%At closeAt close · Mon 19 Oct · ≈ AED 127.46 · Market cap $4.37B · Next earnings Fri 30 Oct

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	76.0%	73.0%	69.9%	73.2%	75.4%	51.4%	—	—
Operating margin	31.4%	24.7%	18.3%	25.1%	24.6%	24.3%	24.3%	+0.0 pts
Net margin	23.0%	21.7%	15.9%	19.6%	20.1%	19.4%	19.4%	+0.0 pts
EBITDA margin	36.0%	31.8%	23.8%	30.2%	29.5%	28.7%	—	—
Return on equity	21.8%	21.8%	17.4%	22.9%	24.3%	23.3%	23.3%	+0.0 pts
Return on assets	17.3%	17.6%	12.6%	17.6%	18.4%	17.2%	17.2%	+0.0 pts
Return on capital employed	28.5%	23.8%	19.2%	27.9%	28.1%	28.0%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.1×	0.1×	+0.0%
Debt / assets	0.8%	0.6%	0.8%	0.8%	0.9%	4.2%	—	—
Interest coverage	107.9×	79.6×	116.4×	145.0×	54.4×	82.2×	—	—
Current ratio	3.1×	3.5×	2.5×	3.0×	2.9×	2.6×	2.6×	+0.0%
Quick ratio	1.9×	2.3×	1.8×	2.1×	1.9×	2.0×	—	—
Cash ratio	0.3×	0.3×	0.3×	0.1×	0.2×	0.1×	0.1×	+0.0%
Asset turnover	0.8×	0.8×	0.8×	0.9×	0.9×	0.9×	—	—
Inventory turnover	0.9×	1.1×	1.4×	1.3×	1.2×	2.8×	—	—
Receivables turnover	3.9×	3.2×	3.5×	3.3×	3.9×	2.9×	—	—
Dividend payout	12.7%	11.5%	15.3%	78.7%	38.0%	33.1%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.